Lilly's Growth in Diabetes and Obesity, and Strong Oncology and Immunology Drugs Create a Wide Moat
Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...
Amgen Q4 Earnings: Strong Pipeline And Label Expansions Justify Buy Rating
Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...
Strong Pipeline Positions FMC for Recovery and Long-Term Growth Despite Diamide Decline
In our view, FMC is at risk for a dividend cut. Should FMC not see profit growth in 2025 and 2026 as expected, the dividend may be reduced or cut alltogether. FMC pays a little less than $300 million ...
precisionmedicineonline4d
Merck Talks Up Pipeline Diversification as Demand for Keytruda, Facing Patent Expirations, Grows
The company's blockbuster drug Keytruda contributed $29.48 billion in sales in 2024, but the first of its patent expirations begins in 2028.
Nvidia Still A Top Pick As Microsoft, Meta Stick With GPUs Despite DeepSeek Challenge: Analyst
BofA Securities analyst Vivek Arya maintained a Buy rating on Nvidia Corp (NASDAQ:NVDA) with a price target of $190.
Gilead: Strong Sales Growth Remains With Veklury And Beyond
Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.
Tax Guru7d
Budget 2025: Analysis of proposed amendments in Income Tax & GST
In terms of GST-specific amendments, Budget 2025 also focused on pre-deposit amounts for GST appeals, reducing penalties for E-way bill violations and introducing a 10% penalty for other infractions.
Vertex Pharmaceuticals' SWOT analysis: cystic fibrosis leader faces pipeline challenges
Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...
Impacts10d
7 Powerful Sales CRM Hacks to Supercharge Your Pipeline
Sales teams are always looking for ways to improve efficiency, close deals faster, and keep leads engaged. A Sales CRM system plays a vital role in managing customer interactions, tracking leads, and ...
F. Hoffmann-La Roche Ltd: Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth
Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.
Exelixis's SWOT analysis: cancer drug maker's stock faces patent cliff, pipeline promise
Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...
FXEmpire.com18d
Revenues, Treatment Pipeline Driving Exelixis Higher
Some recent favorable regulatory rulings also have the company’s pipeline looking more attractive from a future sales perspective. EXEL’s third-quarter results for fiscal 2024 saw revenue of $ ...